Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency
Clinical trial NCT01371825 · COMPLETED
Trial details
- NCT number
- NCT01371825
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-04
- Primary completion
- 2018-01-03
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.